Babestutako beste aminoazido babestuak Bonua deslektatzeko

NO

Aurrealdi

Cas ez

Eskabide

KALITATEAREN ADIERAZPENA

Garbitasun

פomer

Garbitasun espezifikoa

* Max1

Umeltasun

1

Fmoc-cys (acm) -oh

86060-81-3

Bonua deslektiboki

≥99,0

≤0,1

≤0,1

≤0,2

≤1,0

2

Fmoc-cys (mmt) -oh

177582-21-7

Bonua deslektiboki

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

3

FMOC-CYS (4-allylbutyrate) -oh

/

Bonua deslektiboki

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

4

MPA (TRT) -OH

27144-18-9

Sekuentzia amaiera

≥99,5

/

≤0,1

≤0,2

≤1,0

5

Fmoc-th (tbu) -ol

189337-28-8

Octreotide

≥97,0

≤0,3

≤0,5

≤1,0

≤1,0

6

FMOC-D-AR (PBF) -oh

187618-60-6

Desmopressin

≥99,0

≤0,2

≤0,3

≤0,3

≤2,0

7

Fmoc-gly-gly-oh

35665-38-4

Bivalirudin

≥99,5

/

≤0,1

≤0,2

≤1,0

8

Fmoc-gly-gly-gly-oh

170941-79-4

Terlipressin

≥99,5

/

≤0,1

≤0,2

≤1,0

9

Fmoc-gly-gly-gly-gly-oh

/

Bivalirudin

≥99,5

/

≤0,1

≤0,2

≤1,0

10

Fmoc-gly-asp (tbu) -oh

/

Bivalirudin

≥99,5

/

≤0,15

≤0,2

≤1,0

11

Boc-cys (trt) -oh

21947-98-8

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

12

Boc-arg (pbf) -oh

200124-22-7

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

13

Boc-ala-oh

15761-38-3

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

14

Boc-d-phe-oh

18942-49-9

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

15

Boc-gly-oh

4530-20-5

Sekuentzia amaiera

≥99,5

/

≤0,1

≤0,2

≤1,0

16

Boc-lys (boc) -oh.dcha

15098-69-8

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

17

Boc-ser (tbu) -oh

7738-22-9

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

18

Boc-th (tbu) -oh

13734-40-2

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

19

Boc-d-ala-oh

7764-95-6

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

20

Boc-me-oh

2488-15-5

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

21

Boc-tyr (tbu) -oh

47375-34-8

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

22

Boc-d-arg (pdf) -oh

187618-60-6

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

23

Boc-asp (otbu) -oh.dcha

1913/12/8

Sekuentzia amaiera

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

24

Fmoc-homoarg (pbf) -oh

1159680-21-3

EptiFibaturoa

≥98,5

≤0,2

/

≤0,5

≤2,0

25

FMOC-ASP-OTBU

129460-09-9

Thymalfasin

≥99,5

≤0,1

≤0,1

≤0,2

≤1,0

26

Fmoc-tyr (me) -oh

77128-72-4

Karbetocin

≥98,5

≤0,2

≤0,3

≤0,5

≤1,0

27

Fmoc-orn (bok) -oh

109425-55-0

Atosiban

Omnipressin

Daptomycin

≥99,5

≤0,1

≤0,1

≤0,2

≤2,0

28

FMOC-D-TYR (ET) -OH

162502-65-0

Atosiban

≥99,5

≤0,1

≤0,1

≤0,2

≤1,0

29

Fmoc-asp (oall) -oh

146982-24-3

Melananan

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

30

Ac-nle-oh

15891-49-3

Melananan

≥99,0

/

≤0,3

≤0,3

≤1,0

31

Fmoc-nle-oh

77284-32-3

Melananan

Afamelanotze

≥99,0

/

≤0,3

≤0,3

≤1,0

32

Ac-glu (Otbu) -oh

84192-88-1

Argibide-arguinel

Azetil octapeptide-3

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

33

AC-β-ala-oh · dcha

/

Azetil tetrapeptide-5

≥99,0

/

≤0,3

≤0,3

≤1,0

34

FMOC-ß-ALA-OH

35737-10-1

Azetil tetrapeptide-5

≥99,5

/

≤0,1

≤0,2

≤1,0

35

Fmoc-hyp (tbu) -oh

122996-47-8

Icatibante

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

36

Fmoc-thi-oh

130309-35-2

Icatibante

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

37

Fmoc-d-tic-oh

130309-33-0

Icatibante

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

38

Fmoc-oic-oh

130309-37-4

Icatibante

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

39

Boc-sar-oh

13734-36-6

Sareakasin

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

40

Fmoc-sar-oh

77128-70-2

Sareakasin

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

41

Fmoc-tyr (so3na) -oh.h2o

106864-37-3

Egiazki

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

42

FMOC-D-ASP (OTBU) -oh

112883-39-3

Daptomycin

≥98,5

≤0,2

≤0,3

≤0,5

≤1,0

43

Ac-ser (tbu) -oh

77285-09-7

Afamelanotze

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0

44

Boc-homocys (trt) -oh

201419-16-1

Depretidio

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

45

Fmoc-homocys (trt) -oh

167015-23-8

Depretidio

≥98,0

≤0,2

≤0,3

≤0,5

≤1,0

46

Fmoc-dab-oh

161420-87-7

Suge Venom

≥99,0

≤0,2

≤0,3

≤0,3

≤1,0